https://www.selleckchem.com/pr....oducts/Cisplatin.htm
939, P less then 0.001). Structural progression was detected in 45 eyes (84.9%) in the LDS group and 8 eyes (25.8%) in the non-LDS group. Functional progression was demonstrated in 29 eyes (34.5%) in the LDS group and 6 eyes (19.4%) in the non-LDS group. The eyes with LDS had a significantly higher risk of glaucoma progression (χ2 = 5.00, degree of freedom = 1, P = 0.033). Conclusions In eyes with POAG, the presence of LDS was associated with thinner prelaminar tissue and faster disease progression.Current evidence suggests that volit
Like
Comment
Share
